0001140361-15-038813.txt : 20151029 0001140361-15-038813.hdr.sgml : 20151029 20151028185723 ACCESSION NUMBER: 0001140361-15-038813 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151029 DATE AS OF CHANGE: 20151028 EFFECTIVENESS DATE: 20151029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biolytx Pharmaceuticals Corp CENTRAL INDEX KEY: 0001656890 IRS NUMBER: 371514075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-250274 FILM NUMBER: 151181404 BUSINESS ADDRESS: STREET 1: 800 RESEARCH PARKWAY STREET 2: SUITE 334 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 BUSINESS PHONE: 405-271-6593 MAIL ADDRESS: STREET 1: 800 RESEARCH PARKWAY STREET 2: SUITE 334 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 D 1 primary_doc.xml X0707 D LIVE 0001656890 Biolytx Pharmaceuticals Corp 800 RESEARCH PARKWAY SUITE 334 OKLAHOMA CITY OK OKLAHOMA 73104 405-271-6593 DELAWARE None None Corporation true William A Hagstrom 800 Research Parkway Suite 334 OKLAHOMA CITY OK OKLAHOMA 73104 Director H Anne Pereira 800 Research Parkway Suite 334 OKLAHOMA CITY OK OKLAHOMA 73104 Executive Officer Director Douglas A Branch 800 Research Parkway Suite 334 OKLAHOMA CITY OK OKLAHOMA 73104 Executive Officer Pharmaceuticals No Revenues 06b false 2015-10-16 false true true false 25000 1417971 1317971 100000 The total amount sold includes $1,000,000 sold and funded at closing on 10-16-15, $100,000 sold and to be funded in Sept 2016, and $217,971 of preexisting outstanding indebtedness of the company cancelled and converted into the securities sold. false 12 0 0 16000 true Reimbursement of expenses of an officer and director. In addition, $165,417 of the securities were issued in exchange for cancellation of indebtedness of the company in the same amount held by persons in item 3 or affiliates thereof. false Biolytx Pharmaceuticals Corp Douglas A. Branch Douglas A. Branch Secretary 2015-10-28